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Abstract 
 The effects of postural threat on gait initiation and steady state gait among 
Parkinson’s disease (PD) patients and age-matched adults were examined. Ten healthy  
adults (CTRL; mean age= 68.8 ± 8.4, range 56-80 years) and ten PD patients (PDOFF / ON ; 
mean age= 69.7 ± 10.3, range 54-81 years) initiated gait and continued with steady state 
walking along a walkway of two different height conditions. PD patients were first tested in a 
non-medicated state followed by testing in a medicated state. The results showed that gait 
initiation and steady state gait deficits inherent to PD are exacerbated in a postural 
threatening environment. As well, medication efficacy for overcoming parkinsonian deficits 
may be context dependent. These findings confirm the dynamic nature of movement deficits 
characteristic of parkinsonian patients and provide empirical evidence for specific 
environments that can create movement difficulties for people with PD.  
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General Introduction 
1. Introduction 
 Postural control describes the process of maintaining the position of the body in 
space for the purpose of stability and orientation (Shumway-Cook & Woollacott, 2000). 
Normal aging is associated with difficulties in controlling posture (Horak, Diener, & 
Nashner, 1989), a problem manifest by compromised postural stability, gait initiation, and 
steady state gait among the elderly (Tinetti, Speechley, & Ginter, 1988; Brunt, Liu, Trimble, 
Bauer, & Short, 1999; Hass et al., 2004). Balance and locomotion become increasingly 
difficult for adults who have Parkinson’s disease (PD). PD patients have a fall rate that is the 
highest among all neurological diseases, with patients experiencing twice the amount of falls 
that age-matched healthy adults encounter (Stolze et al., 2004). Possible reasons for this 
increased fall rate are the difficulties that PD patients experience in controlling momentum 
during gait initiation (Hass et al., 2004) and the subsequent deficiencies of slow shuffling and 
low ground clearance of the feet during steady state gait (Overstall, 2001). 
 A common observation among patients and therapists alike is that PD motor 
symptoms associated with control of locomotion can fluctuate across environmental 
contexts, with novel or challenging situations exacerbating disease symptoms (Morris, 
Iansek, Smithson, & Huxham, 2000). Specific examples that create difficult situations for PD 
patients include busy road crossings (Fahn, 1995), cluttered home environments (Morris et 
al., 2000; Rochester et al., 2004; Stolze et al., 2004), and narrow spaces (Giladi et al., 1992; 
Macht & Ellgring, 1999). However, despite these observations and patient reports, little 
empirical study has been conducted to document how a challenging environmental context 
can influence motor performance in PD patients. This thesis addresses a critical need to 
determine how challenging environments affect movement patterns among PD patients.  
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 This chapter presents a literature review that serves to demonstrate the potential for 
a modulating effect for environmental context on motor control among patients with PD. 
This literature review has been categorized into four different sections. The Parkinson’s disease 
literature section consists of work that underlines the fundamental principles of the 
hypothesized causes of PD, the influence of PD on motor control, as well as treatment 
methods for the care and management of this disease. The gait initiation and steady state gait 
section presents an overview of the biomechanical principles of gait initiation and steady 
state gait. The third section, gait initiation and steady state gait in Parkinson’s disease reviews 
current research regarding how Parkinson’s disease influences gait initiation and steady state 
gait. The final section, environmental context, explores the role that changes in environmental 
context, and more specifically postural threatening situations, can have on the regulation of 
locomotion.  
2. Parkinson’s Disease Literature  
2.1 Epidemiology 
 PD is a neurodegenerative disease that is characterized by tremor (involuntary 
shaking), rigidity (stiffness surrounding the joint), bradykinesia (slowness of movement), gait 
disturbance, and postural instability. PD is the second most common neurodegenerative 
disease in today’s population and one of the most common causes of disability among the 
elderly (Jankovic, 2002). This disorder affects about 1% of the population over the age of 60, 
and it has been stated that 1 person in 40 will develop parkinsonian symptoms over their 
lifetime (Jankovic, 2002). Advancing age is the most important risk factor for developing 
PD, with the peak onset at age 60 years. However, PD is not just a disease of middle or old 
age: 15% of PD patients are 50 years or less, and 10% are 40 years or less (Jankovic, 2002) .  
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 PD is caused by the degeneration of dopaminergic neurons in the substantia nigra 
pars compacta (SNc). In addition, neuronal loss in the cerebral cortex, anterior thalamus, 
hypothalamus, amygdala and basal forebrain has shown to play a major role in developing 
Parkinson’s disease symptoms (Bowers, Maguire-Zeiss, Harvery, & Federoff, 2001). 
However, almost 80 per cent of brain dopamine is found in the striatonigral complex 
comprising the putamen, caudate, and the SNc (Stewart, 2001) (Figure 1). The putamen and 
caudate receive the majority of dopamine from the dopaminergic neurons located in the 
SNc. Neuronal loss in the SNc is correlated with the extent of dopaminergic depletion in the 
putamen and caudate, with dopamine depletion more evident in the putamen (Stewart, 
2001).  
 
 
 
  
 
 
 
 
 
 
 
 
Figure 1. Diagram of the human brain, highlighted are the basal ganglia 
Adapted from http://cti.itc.virginia.edu  
PD exists as both a sporadic and familial disorder. The common pathway of both sporadic 
and familial PD is a loss of dopamine neurons. Importantly, it has been stated that early 
symptomatic PD can be produced when dopamine neurons reach a number that is below a 
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critical threshold (Duvoisin, 1992). Research shows that cell loss in excess of 50 percent of 
normal levels is required for clinical symptoms to develop (Stewart, 2001). Environmental 
factors such as pesticides, herbicides, industrial chemicals and genetic mutations have been 
identified as potential risk factors for PD. It is theorized that either alone or in combination, 
these triggers can play a role in developing PD symptoms (Olanow & Tatton, 1999). Bowers 
(1997) suggests a ‘common pathway’ model that involves the theory that multiple triggering 
mechanisms such as genetic, toxicant and environmental triggers plus genetic vulnerability, 
increases the risk of cell death. To date there has been no cure to either eradicate all 
symptoms for life or to replenish dopamine producing cells. 
2.2.Anatomical Review 
 The degeneration of the dopaminergic nigrostriatal projections in the basal ganglia 
leads to disruption of the motor circuit. Both voluntary and involuntary movements are 
controlled by this circuit, which is comprised of several subcircuits which interact in a 
complex manner (Stewart, 2001) (Figure 2).  
 The function of the basal ganglia in controlling movement is governed by excitatory 
and inhibitory outputs. The venterolateral thalamus (VL) has an excitatory output to the 
motor cortex and thus acts to facilitate movement. On the other hand, the globus pallidus 
interna (GPi) and the substantia nigra pars reticulata (SNr) have an inhibitory output to the 
VL and thus acts like a brake on movement. The GPi receives input from the putamen via 
two pathways: 1) the direct pathway and 2) the indirect pathway. The direct pathway runs 
from the putamen to GPi and its effects are inhibitory (ie. to release the brake on movement 
exerted by GPi). The indirect pathway runs from the putamen via globus pallidus externa 
(GPe) and subthalamic nucleus (STN). STN has an excitatory effect on GPi and the 
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resulting effect is to increase the braking on movement from GPi. Normal dopamine 
released from the SNc acts on both these pathways. 
 
 
 
 
 
 
The role of dopamine D1 receptors is to stimulate the direct pathway, this action results in a 
decrease of the braking effect on movement from GPi. By acting on dopamine D2 
receptors, the indirect pathway is inhibited, decreasing the stimulus for GPi to exert a 
braking effect. Normal SNc function therefore results in a low braking effect from GPi to 
VL and thus allows VL to facilitate movement via its excitatory effects on the motor cortex 
(Stewart, 2001). 
Putamen 
         D2          D1 
SNc 
GPe 
Ventrolateral 
Thalamus 
Brain Stem/ 
Spinal Cord 
STN GPi / SNr 
Figure 2.The basal ganglia. Open arrows represent excitation; solid arrows indicate inhibition.  
    Adapted from Stewart, 2001 
Cortex 
 5
 In PD, decreased dopamine release from SNc disrupts this complex mechanism. 
Understimulation of the direct pathway and underinhibition of the indirect pathway result in 
an increased inhibitory output or increased braking effect from the GPi. Thus, the excitatory 
effects of VL on the motor cortex are diminished and movement inhibited (Stewart, 2001). 
It has been stated that abnormal functioning of the direct and indirect pathways is the cause 
of dyskinesias and motor fluctuations within advanced cases of PD (Elble, 2002). 
2.3 Basal Ganglia Function 
 The basal ganglia are involved in the maintenance of motor, cognitive, and patterned 
and sequential behavior such as locomotion (Hindle, 2001). One role of the basal ganglia is 
to maintain cortically preselected movement amplitude during repetitive movements (Morris, 
Iansek, McGinley, Matyas, & Huxham, 2005). Although the basal ganglia do not directly 
scale movement size, these structures are responsible for matching performance outcomes 
with original motor plans (Iansek, Bradshaw, Phillips, Morris, & Cunnington, 1995). In an 
example of stride length amplitude in gait, the motor cortical regions are responsible for 
selecting movement amplitude based on the desired outcome or goal of the task, for 
example stepping over an obstacle. The role of the basal ganglia is to provide the correct 
motor response and appropriately timed cues to enable the motor plan to run to completion 
and allow the patient to achieve a successful step over the obstacle. This is advantageous to 
locomotion because the cortex is ‘freed up’ to control other tasks that require attention 
(Bond & Morris, 2000). It is believed that the basal ganglia in the PD brain cannot match the 
preselected motor plan to the intended amplitude. Consequently, a mismatch between the 
pre-selected and actual amplitude of movement occurs. In the hypothesized situation 
presented, this would lead to a shorter step and possible obstacle contact (Morris et al., 
2005).  
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2.4 Treatment 
 Pharmacological and medical treatments exist to combat the symptoms and 
movement difficulties of PD. Drug therapy remains the primary intervention to treat PD, 
with levodopa replacement being the most effective drug strategy to treat the symptoms of 
this disease. Levodopa medication is used by depleted dopaminergic neurons to increase 
synaptic dopamine concentrations (Playfer, 2001). In addition, levodopa replacement has 
been shown to be effective in improving locomotor deficits associated with PD (Burleigh-
Jacobs, Horak, Nutt, & Obeso, 1997). The alleviation of bradykinesia and rigidity helps PD 
patients ambulate more effectively within activities of daily living. In the task of gait 
initiation levodopa medication has been shown to be effective in improving force 
production and increasing velocity of movement (Burleigh-Jacobs, Horak, Nutt, & Obeso, 
1997), both factors that have been implicated to reduce the likelihood of sustaining a fall 
during gait initiation (Cummings & Nevitt, 1989).  For steady state gait, levodopa medication 
has been shown to improve the range of motion achieved at the hip, knee, and ankle joints 
throughout the gait cycle (Shan, Lee, Chao, & Yeh, 2001). In addition, stride length, stride 
velocity, and foot ground clearance also increase when levodopa is used (Knutsson, 1972; 
Morris et al., 2005).    
Summary 
 The symptoms of rigidity, tremor, bradykinesia, and postural instability can be very 
incapacitating for patients with PD. These symptoms are the result of a loss of dopamine 
producing neurons in the basal ganglia of the brain. The motor cortex relies on the basal 
ganglia to maintain preselected movements. However, in PD patients dopamine depleted 
basal ganglia create a mismatch between preselected and actual movement amplitudes; the 
result are substantial movement deficiencies. There are attempts to relieve some of the 
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symptoms of PD through drug therapy, however no cure has been found to eradicate all 
symptoms associated with this disease. Further understanding and continued research of the 
basal ganglia, medication effectiveness, and the impact of this disease on movement is 
needed to implement improved treatment techniques and effective therapeutic strategies. 
3. Gait Initiation / Steady State Gait  
Relevant Background: Biomechanics of gait initiation and steady state gait 
3.1 Gait Initiation 
 The intricate relationship between center of pressure (COP) and center of mass 
(COM) is a fundamental concept that must be investigated prior to the discussion of gait 
initiation. COM is the weighted average of the COM of each body segment in 3D space. 
Balance is maintained when the vertical projection of the COM on the ground is kept within 
the support base of the body, which is defined by the boundaries of the feet. In contrast, 
COP is the location of the vertical reaction force that is projected onto the ground, and as 
such, represents a weighted average of all force acting on the ground. The position of the 
COP depends on the relative weight distribution between the feet (Winter, 1991). 
  The initiation of gait is a task that challenges balance because of the requirement to 
move from a relatively static position to periodically unstable gait. The gait initiation process 
requires the coordination of anticipatory postural adjustments to move the COM forward 
and over the stance leg (the second leg to leave the ground) (Figure 3). This shift in body 
mass is essential to achieving single-limb support during the first step.  
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 Gait Initiation 
Swing Leg 
Stance Leg
 
Figure 3. Gait initiation process, figure depicts single-limb support and corresponding swing leg 
and stance leg.  
The postural adjustments involved in gait initiation produce both vertical and horizontal  
forces that move the COP from a location between the feet, to a position backwards and 
toward the swing leg (Figure 4). This process is referred to as the initiation phase, and is 
characterized by the COM moving forward and laterally over the stance leg (Burleigh-Jacobs 
et al., 1997). The COP then moves laterally towards the initial stance leg, and as a result the 
COM completes positioning over the initial stance leg. This phase is referred to as the transfer 
phase. It is midway through the transfer phase that the heel of the foot from the initial swing 
leg lifts off the ground. This is closely followed by the toe of the foot from the initial swing 
leg lifting off the ground and is achieved when the COP reaches the most lateral position 
under the stance leg (Dibble et al., 2004).  
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COM 
COP 
 
 
 
Figure 4. COP and COM movement pattern. The COP begins at a static position between the feet (dark circle). 
Initiation phase consists of the COP moving backwards and lateral towards the initial swing leg. COP then moves 
laterally toward the initial stance leg, referred to as the transfer phase. The COM moves forward and laterally toward 
the initial stance leg. 
Adapted from Dibble et al., 2004 
3.2 Steady State Gait 
 The human body is inherently unbalanced due to two-thirds of our body mass being 
located two-thirds of our body height above the ground. As a result, the central nervous 
system (CNS) is in a constant challenge to maintain our COM within our base of support 
(Winter, 1991). Gait is a challenging task because locomotion is dependent on the continued 
self-initiation of a fall, whereby the COM moves beyond the base of support. Bipedal gait 
involves alternating sequences of movement in which the body is supported first by one 
limb, which is contacting the ground, and then by the other limb. The period of support in 
which both feet are in contact with the ground is referred to as double-limb support (DLS) 
and the period in which only one foot is in contact with the ground is referred to as single-
limb support (SLS) (Figure 5). These intervals are marked by two events: 1) heel contact: the 
time at which the heel contacts the ground and 2) toe off: when the opposite foot leaves the 
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ground. Gait cycles are defined relative to these events. For example, one complete gait cycle 
is typically from the right foot leaving the ground to when the right foot leaves the ground a 
second time, this process is defined as one stride (Enoka, 1994).  
 
 
  
Gait Initiation Steady State Gait 
Swing Foot 
time
Double-Limb SupportInitiation 
2nd Heel Strike2nd Toe-off 1st Heel StrikeGO 1st Toe-off 
Single-Limb Support
    Stance Foot 
 
 
Figure 5. Illustration of human gait and the different support phases of the gait cycle. 
Summary 
 Locomotion is produced by successful gait initiation and the continuation of steady 
state gait. Gait initiation is comprised of an intricate relationship between COP and COM 
dynamics. The goal of gait initiation is to produce a sufficient amount of force that will 
generate the momentum necessary to move the COP first towards the swing-leg and then 
towards the stance-leg. The result is a transfer of the location of the COM toward the 
stance-leg, thus enabling a step to be taken safely. Steady state gait is characterized by 
continuous gait cycles which consist of a SLS phase and a DLS phase. Together these two 
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movement processes provide adequate opportunity to study human movement and possible 
modifications or adaptations made by age, disease, or environment.   
4.0 Gait Initiation and Steady State Gait in PD   
 
4.1 Gait Initiation 
 For patients with Parkinson’s disease, gait initiation disorders emerge concomitantly 
with problems associated with postural control (Vaugoyeau, Viallet, Mesure, & Massion, 
2003). On physical examination, the gait initiation impairment can be aggravated to such an 
extent that the patient becomes “frozen to the spot” (Narabayashi, 1980) or “suddenly 
blocked” (Giladi et al., 1992). As Vaugoyeau et al. (2003) suggest, these freezing episodes 
indicate that the impairment of gait initiation could reach a stage beyond which step 
triggering would no longer be possible. This is significant because such a severe impairment 
could lead to an increase in fall rate. Many patients report falling when they freeze because 
their feet remain fixed on the ground while their upper body continues to move or turn 
(Overstall, 2001). 
 The parkinsonian posture and the subsequent symptoms of PD have a considerable 
effect on gait initiation. The parkinsonian posture is described as a ‘stooped posture’ with 
the neck and head inclined forward and the trunk flexed forward. As well, the dorsal spine 
shows kyphosis (Knutsson, 1972). Moreover, the arms are slightly abducted, the elbows are 
flexed and the hands are carried in front of the body with the fingers partially flexed. In 
addition, the hips and knees are flexed, and the angle of the ankle decreases as the disability 
increases, which causes PD subjects to stand more on their toes compared to adults of the 
same age without the disease (Knutsson, 1972) (Figure 6).  
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Figure 6. Illustration of the typical parkinsonian posture.
Adapted from www.va.gov
 Previous research has shown that persons with PD exhibit increased movement 
time, decreased movement amplitude, and decreased velocity through all phases of gait 
initiation when compared to healthy older adults (Dibble et al., 2004). More specifically 
during the initiation phase (refer to figure 7) of gait initiation, persons with PD exhibit 
decreased posterior and lateral displacement of the COP compared to older adults without 
PD (Dibble et al., 2004). As well, Halliday et al. (1998) showed that during this phase, despite 
the decreased COP displacement PD patients took longer to initiate gait. Likewise during the 
transfer phase (refer to figure 7) PD patients have shown to not only take longer to complete 
this phase, but do so with a slower velocity. These results may suggest why PD patients also 
have a shorter step length when initiating gait (Halliday, Winter, Frank, Patla, & Prince, 
1998).  
 Interestingly, the deficiencies that PD patients exhibit in gait initiation have been 
found to improve with the use of levodopa medication. In particular, Burleigh-Jacobs et al. 
(1997) showed that levodopa medication reduced movement duration, and increased force 
production and velocity. These improvements may explain why the COP and COM 
trajectories during gait initiation still remain similar to healthy older adults despite the  
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reported deficiencies in timing, velocity, and amplitude (Halliday et al., 1998).  
 
Young Adults 
Older Adults 
PD  
Figure 7. COP trace for gait initiation. Comparison between healthy older adults (broken line) and PD patients 
(thin line) 
Adapted from Halliday et al., 1998 
4.2 Steady State Gait  
 Recent research has confirmed that PD patients experience a greater number of falls 
compared to healthy older adults and that the majority of these falls occur during 
locomotion (Ashburn, Stack, Pickering, & Ward, 2001; Bloem, Valkenburg, Slabbekoorn, & 
van Dijk, 2001). The explanation of high fall risk and incidence may lie within the 
parkinsonian posture (Schaafsma et al., 2003). PD gait is characterized by a stooped posture, 
reduced arm movements, reduced gait velocity, and reduced stride length (Schaafsma et al., 
2003), which results in  a slow shuffling pattern. This type of walking pattern is characterized 
by a reduction in knee flexion and heel elevation, as well as increased flexion of the trunk. In 
advanced stages of PD, gait becomes reduced to sliding of the feet and forward movement is 
accomplished through short quick steps. The influence of dysfunctional basal ganglia cannot 
be discounted as a primary cause of these deficits. It is proposed that the short steps PD 
patients take during gait is the result of a loss of automaticity in the ability to create smooth 
sequential movements, and that PD gait is comprised of separate small steps (Overstall, 
2001).    
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 Despite these deficits, levodopa medication has shown to be beneficial in reducing 
the difficulties that PD patients encounter during steady state gait. Levodopa therapy has 
been shown to increase stride length, stride velocity, steps per minute, as well as reducing the 
amount of time spent in double limb support (Blin, Ferrendez, Pailhous, & Serratrice, 1991; 
Morris et al., 2005).  These results would suggest that dopamine may regulate the amplitude 
of the gait motor plan (Overstall, 2001). 
Summary  
 The tasks of gait initiation and steady state gait are essential for activities of daily 
living. However for PD patients, these tasks can become very difficult and disabling. 
Research has shown that PD patients initiate gait with smaller amplitude, slower velocity, 
and longer duration compared to healthy older adults. For steady state gait, reduced stride 
length, slower stride velocity and walking speed, as well as an increase in DLS characterizes 
the deficiencies that PD patients exhibit. The proposed source of these deficits stems from 
dysfunctional basal ganglia, with both gait initiation and steady state gait parameters 
improving with levodopa medication.  
5.0 Environmental Context  
 Movement is constantly being adapted or modified to suit the environment. For 
example, when walking on an icy surface our movement changes to adapt to the 
environment and the result is a more cautious and conservative movement pattern. The 
adaptability of the CNS to modulate movement in response to a challenging or changing 
environment is crucial to the success of goal-directed movement. Numerous studies have 
addressed the need for investigating the role of environmental context on locomotion; 
changes in surface, obstacle negotiation, and postural threatening situations have 
unequivocally demonstrated locomotion is modulated to meet the demands imposed by the 
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environment (McKenzie & Brown, 2004; Brown, Gage, Polych, Sleik, & Winder, 2002; 
Brown, McKenzie, & Doan, in press). 
 Anecdotal observations and patient reports indicate that PD patients have increased 
movement deficiencies in challenging environmental contexts (Morris et al., 2000). For 
example, busy road crossings (Fahn, 1995), cluttered home environments (Morris, 2000; 
Rochester et al., 2004; Stolze et al., 2004) and narrow spaces (Giladi et al., 1992; Macht & 
Ellgring, 1999), are a few of the challenging environments that affect movement for PD 
patients. Yet, beyond patient report and clinical observation, further research is vital to 
understanding how challenging environmental contexts influence movement among PD 
patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 16
Objective of the Thesis 
 The purpose of this thesis was to explore how patients with PD modulate the 
initiation and control of gait in an environmental context that presents a threat to postural 
control. Moreover, this thesis also examined whether environmental context influences the 
efficacy of levodopa therapy for alleviating typical locomotor-dependent symptoms of 
Parkinson’s disease. 
 In accordance with previous work from our laboratory the postural threat 
environment consisted of two testing conditions. 1) A floor condition (non-elevated, low 
postural threat), in which subjects initiated gait and continued with steady state gait while 
walking on the ground, and 2) an elevated condition (increased postural threat) in which all 
subjects initiated gait and continued with steady state gait while walking on the elevated 
surface.  
 It was hypothesized that Parkinson’s disease patients in the postural threatening 
environment would show an increase in the already disabling motor deficits. In addition, it 
was hypothesized that the efficacy of parkinsonian medication may be compromised in the 
elevated testing condition. This hypothesis was based on patient reports and anecdotal 
evidence suggesting PD patients have difficulties with movement in challenging 
environments.  
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Deficits of Gait Initiation and Steady State Gait are Exacerbated by 
Postural Threat in Parkinson’s Disease Patients 
1. Introduction 
 Balance and locomotor deficits are among the hallmark symptoms of Parkinson’s 
disease (PD) (Morris et al., 2000; Morris, 2000; Morris, Huxham, McGinley, Dodd, & Iansek, 
2001; Nilsson, Tornqvist, & Rehncrona, 2005; Sohng, Moon, & Lee, 2004), and it is now 
recognized that these symptoms contribute to the high prevalence of falls in this population 
(Bloem et al., 2001; Gray & Hildebrand, 2000; Grimbergen, Munneke, & Bloem, 2004). It is 
this increased risk of falling (Wielinski, Erickson-Davis, Wichmann, Walde-Douglas, & 
Parashos, 2005), and the concomitant fear of falling (Adkin, Frank, & Jog, 2003), which 
develop with this disease that deprives patients of confidence and locomotor ability. This 
contributes to a loss of functional independence (Capecci et al., 2005), and a decrease in the 
subjective impression of physical and emotional functional quality of life (Chapuis, 
Ouchchane, Metz, Gerbaud, & Durif, 2005).  
Currently, there is an extensive knowledge base confirming parkinsonian deficits in 
locomotor control during gait initiation (Crenna & Frigo, 1991; Gantchev, Viallet, Aurenty, 
& Massion, 1996; Halliday et al., 1998) and steady-state gait (Bowes et al., 1990; Morris et al., 
2005; Schaafsma et al., 2003) compared to age-matched non-neurological participants. A key 
finding to emerge from these studies is that movement deficits are exacerbated in situational 
contexts that impose added motor or cognitive demands, such as walking while carrying a 
tray of glasses (Bond & Morris, 2000; Canning, 2004) or performing a cognitive task 
concurrent to gait initiation (Melzer, Benjuya, & Kaplanski, 2003) or gait (Rochester et al., 
2004). Disease-related degeneration of dopamine-producing cells in the substantia nigra 
causing excessive inhibition of striatothalamic output and a lack of facilitation to the motor 
area of the cortex (Burch & Sheerin, 2005; Lefaucheur, 2005) provides foundation for 
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parkinsonian motor deficits in non-challenging contexts (Morris, 2000). The exacerbated 
deficit seen in situational contexts that impose added motor or cognitive demand is 
suggested to reflect a compromised ability to direct cognitive resources to movement 
execution, a strategy used by PD patients to overcome movement deficits (Morris, 2000). 
Yet, despite these findings, anecdotal evidence and clinical observations indicate that the 
motor symptoms associated with the movement disorder of PD also fluctuate across 
environmental contexts, with novel or challenging contexts exacerbating disease symptoms 
(Morris, 2000). For example, cluttered home environments (Morris, 2000; Rochester et al., 
2004; Stolze et al., 2004), busy road crossings (Fahn, 1995), and narrow spaces (Giladi et al., 
1992; Macht & Ellgring, 1999) are reported to make disease symptoms more troublesome 
for PD patients. 
The environmental context in which a movement is performed plays a significant 
role in how the movement is expressed. Numerous examples of this phenomenon across a 
diverse range of movements are available in the literature, each providing justification for the 
adaptability of human movement. The existence of adaptability ensures task execution 
despite any imposed constraints. Extensive research on healthy older adults demonstrates 
how gait patterns are modulated to accommodate environmental constraints that increase 
the risk for falling and/or present the possibility for injurious consequences should a fall 
occur. Gait pattern adjustments according to the presence and characteristics of obstacle 
contingencies (Chen et al., 1996; Zettel, McIlroy, & Maki, 2002), or the conditions and 
challenge imposed by the walking surface (Brown, Gage et al., 2002; Marigold & Patla, 2002; 
Richardson, Thies, DeMott, & Ashton-Miller, 2004) substantiate this now well-documented 
finding. Yet, despite these observations, the effect of environmental context on motor 
symptoms of PD remains unexplored beyond clinical observation and patient report. Our 
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purpose in this study was to explore the effect of environmental context on locomotor 
control among patients with PD. We incorporated the elevated platform paradigm as a 
manipulation of environmental context. This paradigm presents a threat to postural control 
by a heightened potential for injurious consequences (Brown, Gage et al., 2002; Gage, Sleik, 
Polych, McKenzie, & Brown, 2003; McKenzie & Brown, 2004). Following clinical report of 
aggravated parkinsonian symptoms in challenging environmental contexts, we expected that 
locomotor deficits inherent to the processes of gait initiation (Halliday et al., 1998) and 
steady-state gait (Morris et al., 2005) among PD patients would be exacerbated in the 
threatening environmental context. We suggest this work addresses the documented need 
for research studies investigating how environmental context influences motor performance 
in people with PD (Morris, 2000). 
2. Methods 
2.1Participants 
 Ten levodopa dependent (mean age= 69.7 ± 10.3, range 54-81 years) PD patients 
and ten age-matched healthy control subjects (mean age= 68.8 ± 8.4, range 56-80 years) 
participated in this study. All participants provided their informed consent prior to the 
beginning of testing. Clearance to conduct this study was provided by the Human Research 
Ethics committee of the University of Lethbridge. All control participants were free from 
any neurological disease or any other medical conditions that may affect gait function. PD 
subjects were recruited from local PD support groups and invited to participate if they were 
able to ambulate independently. Patients had mild to moderate severity PD according to the 
Hoehn and Yahr scale (Hoehn & Yahr, 1967). All subjects completed a questionnaire prior 
to testing to determine medical history, medication use, and fall history. Table 1 provides a 
summary of clinical characteristics of PD subjects as well as details relevant to falls history.  
  
Table 1A: PD Subject Demographics      
Subject 
 
Age 
(years) 
Gender 
 
Years 
Diagnosed
Hoehn and Yahr 
(off/on) 
UPDRS III 
(off / on) 
 
Medication 
 
Daily Dosage 
of L-Dopa 
Number of Falls 
Last Year 
1 81 M 7 2.0 / 2.0 33 / 16 Sinemet CR / Mirapex 160mg / 100mg 1 
2 54 F 10 1 / .5 14 / 5 Sinemet CR / Permax 160mg / 1mg 0 
3 54 F 22 2.5 / 1.5 43 / 21  Sinemet CR / Mirapex 50mg / 1mg 1 
4 80 F 2 3 / 2.5 54 / 38  Sinemet CR / Amantadine 100mg / 100mg 1 
5 75 M 2 1.5 / 1 17 / 6 Sinemet 100mg 1 
6 63 F 1.5 3 / 1.5 58 / 22 Sinemet  200mg 3 
7 65 F 11 2.5 / 1 34 / 21   Sinemet CR / Mirapex 50mg / 1mg 1 
8 80 M 15 3 / 2.5 45 / 28 Sinemet  100mg 0 
9 69 M 4 3.0 / 1.0 40 / 18 Sinemet 100mg 1 
10 76 M 8 1.5 / 1 24 / 6   Sinemet/Sinemet CR   100mg / 160mg  0 
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Table 1B: CTRL Subject Demographics 
Subject Age Gender Number of Falls  
 (years)   Last Year 
1 56 F 0 
2 57 F 0 
3 77 M 0 
4 80 M 0 
5 73 F 0 
6 62 F 0 
7 69 F 1 
8 74 F 1 
9 75 M 0 
10 65 F 0 
 
 
 
 
 
 
 
 
PD patients were tested in the non-medicated state (PDOFF: following a minimum 12 hour 
withdrawal of anti-Parkinsonian medication), and post medication (PDON:minimum one 
hour post medication). All patient testing was conducted on the same day with “off” state 
testing occurring first for all patients. The motor subscale component of the UPDRS (Fahn 
and Elton, 1987) was used to assess disease severity in each subject for both the “off” and 
“on” medication states. PD subjects also self-reported on the quality of their medicated state 
to confirm a good “on”. 
2.2 Manipulation of Environmental Context 
 Participants were asked to walk the length of a walkway, which was 4.70 m in length 
and 0.60 m wide, in two environmental context conditions. In one testing condition (floor) 
the walkway was outlined on the floor using black tape strips, in the other condition 
(elevated) the walkway was 0.60m above the ground (See Figure 8). The elevated walkway 
system was constructed of wood and was rigidly connected to maximize stability. Two force 
platforms (Bertec Corporation, Columbus OH) were placed side by side at the leading edge 
of the walkway in each testing condition. In the elevated condition the force platforms were 
placed on top of a hydraulic lift (Pentalift, Guelph Ontario) and were flush with the 
walkway. In the non-elevated testing condition a ramp (length 0.9 m, inclination angle of 5.5 
degrees) was used to bridge the height differential between the force platforms (0.09 m) and 
the ground (0.0 m)(See Figure 8). 
2.3 Instrumentation 
 Infrared-reflective markers were placed bilaterally at the head of the fifth metatarsal, 
lateral malleolus, heel, lateral epicondyle of the femur, iliac crest, lateral epicondyle of the 
humerus, acromion process, and single markers were placed on the sternal notch and 
forehead. Kinematic data were collected using a 6-camera infrared motion analysis data 
 23
collection system (Peak Performance Technologies and Peak Motus 2000 software, 
Englewood, Colo.) at a collection frequency of 120 Hz. Ground reaction force and moment 
of force data were collected from each force platform at a sampling frequency of 600 Hz and 
stored off-line for further analysis. Kinematic and force plate data were collected 
synchronously using the Peak Performance system. In addition, frontal and sagittal digital 
video was captured using tripod-mounted digital video cameras. 
 
 
 
 
 
 
 
 
 
 
 
A)
Figure 8. Two testing conditions. A) Floor condition and B) Elevated condition 
B)
2.4 Protocol 
 All subjects began each trial by standing with each foot on a separate force platform. 
Foot positions were marked prior to the first data collection to ensure consistency between 
trials. Participants were asked to walk at a comfortable speed across the entire length of the 
walkway. Subjects were instructed to initiate gait following the onset of an auditory cue and 
to walk the entire length of the walkway without stopping. There were no restrictions placed 
on the selection of the limb or speed used for gait initiation.  
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There were 18 test trials and one practice trial in each testing condition. Fifteen of 
the eighteen trials for each testing condition involved an obstacle avoidance task. These data 
were collected for future research and were not included in this thesis. The remaining three 
trials were void of any obstacle and provided the data for the results presented in this thesis. 
Trial order was fully randomized within each condition, and the order of test condition 
(floor/elevated) was counterbalanced between subjects. This method was used to prevent 
carry over between testing conditions. All participants wore a T-shirt, shorts, comfortable 
walking shoes, and a safety harness over their clothes while being tested. When walking on 
the elevated walkway the safety harness was attached to a coupling that moved along a steel 
track anchored to the ceiling above the walkway. All participants were guarded by a spotter 
who walked behind the subjects for each test trial. 
2.5 Data processing  
 Custom written algorithms were used to process kinematic and analog data and to 
determine event occurrences (Matlab, The MathWorks, Natick MA USA). Raw marker data 
were filtered using a 4th order Butterworth low pass digital filter at a cut-off frequency of 10 
Hz. Whole-body center of mass (COM) in the anterior-posterior dimension was calculated 
using a 7-segment model using the anthropometric values provided by Winter (1990). These 
segments included the foot, leg, and thigh bilaterally, and the trunk (including arms and head 
with the trunk segment). COM velocity was calculated using the finite differences method. 
Force platform data were filtered using a 4th order Butterworth low pass digital filter at a cut-
off frequency of 10 Hz. Coordinates for the anterior-posterior (y) and medial-lateral (x) 
positions of the center of pressure (COP) from each force plate were calculated using the 
following equation:     
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Fz
MyCOPx =  
 
Fz
MxCOPy =   Where M = moment of force and F = force  
The net COP location between the two force platforms was then calculated using the 
algorithm provided by Winter et al.(1991): 
 ⎟⎠
⎞⎜⎝
⎛
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⎛
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Where COPL and COPR are the COP from under the left and right foot respectively; RL and  
 
RR are the ground reaction forces from the left and right foot respectively. 
 
2.6 Measures of Interest   
Gait Initiation 
 Previous studies of gait initiation have separated the COP trace into different phases 
based on specific events (Dibble et al., 2004; Hass et al., 2004; Martin, 2002). Accordingly, 
we identify three events that occur consecutively in time: COPONSET, COPRELEASE, and 
COPUNLOAD (Figure 9). COPONSET is described as the first detected COP movement after the 
audio signal. COPRELEASE is determined as the maximum lateral and posterior COP 
displacement towards the extremity taking the first step. COPUNLOAD is defined as the point at 
which lateral deviation of COP crosses the midline of the two force platforms to terminate 
under the stance limb, prior to anterior displacement. This event was determined using a 
velocity algorithm. These events were then used to separate the gait initiation cycle into two 
phases: initiation (INIT) and transfer (TRANS). INIT consists of the period from the 
COPONSET to COPRELEASE, and TRANS is defined as the period between COPRELEASE and 
COPUNLOAD (Figure 9). Five dependent variables were established for each phase: 1) Event 
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Time, defined as the absolute duration of time between relevant events, 2) Resultant (RST) 
COP displacement, defined as the total displacement between relevant events independent 
of direction, 3) Medial-lateral (ML) COP displacement, defined as the range of COP 
displacement in the ML dimension between relevant events, 4) Anterior-posterior (AP) COP 
displacement, defined as the range of COP displacement in the AP dimension between 
relevant events, and 5) Peak COP velocity, defined as the maximum velocity reached within 
each phase.  
 
 
 
 
 
 
 
Figure 9. COP trace. Highlighted are three specific events: 1) Onset, 2) Release, 3) Unload. As well as two 
specific phases: 1) Initiation phase and 2) Transfer Phase. Dependent variables were measured using these 
events and phases.  
Steady State Gait 
 Kinematic data were cropped into gait cycles using the event of right heel contact. 
For each trial we used the last gait cycle captured by the motion analysis system (minimum 
4th gait cycle). Kinematic measures include: 1) Stride length, 2) Stride velocity, 3) COM 
velocity in the AP direction, and 4) Percentage of gait cycle duration spent in double limb 
support (%DLS), as per our previous work in this area (Brown et al., 2001).  
2.7 Statistical Analysis  
 Subject anthropometric and demographic details were compared between groups 
using independent t-tests. The effect of postural threat on gait initiation and gait was 
assessed using separate (PDOFF/CTRL, PDON/CTRL, PDON/PDOFF) Group x Height 
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(elevated/non-elevated) Repeated Measures Multivariate Analyses of Variance (RM 
MANOVA) for each category of measures. Factors found to be significant in the 
multivariate analyses were followed up by univariate analyses: separate (PDOFF/CTRL, 
PDON/CTRL, PDON/PDOFF) Group x Height (elevated/non-elevated) Repeated Measures 
Analyses of Variance (RM ANOVA). Bonferroni adjusted pairwise comparisons were used 
as post-hoc analysis for significant univariate RM ANOVA results. Results were considered 
significant at the 0.05 level. 
3. RESULTS 
 Results are presented independently for the tasks of gait initiation and steady state 
gait. A summary of statistical findings for gait initiation and gait are provided in Tables 2a 
and 2b respectively. Descriptive statistics detailing the effects of Group and Height for each 
task are provided in Tables 3a and 3b. 
3.1 Subject Characteristics 
 There were no significant differences between groups in height or body weight 
(height: t(18) = 0.15, p>.05; body weight: t(18) = 0.25, p>.05). However, there was a trend 
that was nearing significance when comparing number of falls in the past year between 
groups (t(18) = 2.26, p= .077). Only two CTRL subjects reported falling in the past year, 
while six PD subjects also reported falling in the last year. 
 
 
 
 
 
 
   Table 2a:  Summary of statistical findings for gait initiation.   
INITIATION  
PHASE 
PDOFF vs. CTRL PDON vs. CTRL  PDON vs. PDOFF 
Height Group 
Height 
x 
 Group 
 
Height 
 
Group 
Height 
x  
Group    
 
Height 
 
Group 
Height 
x 
Group 
MANOVA * * *      *   
Event Time  * * *      *   
RST COP  
Displacement     
        
ML COP  
Displacement     
        
AP COP 
Displacement    * 
     *   
Peak COP  
Velocity     
        
 
TRANSFER 
PHASE 
PDOFF vs. CTRL PDON vs. CTRL    PDON vs. PDOFF 
Height Group 
Height  
x 
Group 
Height Group 
Height 
x 
 Group 
 Height Group 
Height  
x 
Group 
MANOVA  *   * *** *  *   
Event Time  0.061 *   *** * *  *   
RST COP  
Displacement   *  
        
ML COP  
Displacement   *  
  0.082      
AP COP 
Displacement  *   
 0.082       
Peak COP  
Velocity   *  
 0.094  *  *   
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* 
*p<.05; ***p<.001 
   Table 2b:  Summary of statistical findings for steady state gait.   
 
 STEADY 
STATE 
GAIT 
PDOFF vs. CTRL PDON vs. CTRL  PDON vs. PDOFF 
Height Group 
Height  
x  
Group 
Height Group 
Height 
x 
Group 
Height Group 
Height 
 x 
Group 
MANOVA * *** *  * *** *  *** 0.088  
Stride Length  * *** 0.074  * *** *  *   
Stride Velocity  0.076 ***   * *** *  *   
AP COM  
Velocity  * *** * 
 * *** *  *   
%DLS  0.073 *** *   ***   *   
 
 
 
 
 
 
 
 
 
 
 
 
      *=p<.05; ***p<.001 
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Table 3a:  Summary of descriptive statistics for gait initiation for each condition of postural threat.   
      Data are presented as mean ± standard error for each test group. 
 
INITIATION  
PHASE 
FLOOR ELEVATED 
CTRL PDON PDOFF CTRL PDON PDOFF 
Event Time (s) 0.39 (0.08) 0.60 (0.06) 0.72 (0.13)  0.37 (0.08) 0.76 (0.13) 1.04 (0.09) 
RST COP  
Displacement (m) 0.023 (0.03) 0.026 (0.006) 0.017 (0.01)  0.029 (0.03) 0.014 (0.006) 0.024 (0.01) 
ML COP  
Displacement (m) 0.02 (0.01) 0.02 (0.01) 0.008 (0.01)  0.02 (0.01) 0.009 (0.01) 0.013 (0.01) 
AP COP 
Displacement (m) 0.015 (0.01) 0.017 (0.01) 0.013 (0.01)  0.016 (0.01) 0.007 (0.002) 0.002 (0.003) 
Peak COP  
Velocity (m/s) 0.23 (0.05) 0.24 (0.05) 0.10 (0.05)  0.17 (0.02) 0.12 (0.02) 0.11 (0.02) 
 
TRANSFER 
PHASE 
FLOOR ELEVATED 
CTRL PDON PDOFF CTRL PDON PDOFF 
Event Time (s) 0.24 (0.09) 0.48 (0.09) 0.53 (0.10)  0.29 (0.04) 0.67 (0.09) 0.67 (0.14) 
RST COP  
Displacement (m) 0.05 (0.02) 0.04 (0.03) 0.03 (0.01)  0.05 (0.04) 0.03 (0.01) 0.03 (0.01) 
ML COP  
Displacement (m) 0.04 (0.01) 0.026 (0.01) 0.025 (0.01)  0.05 (0.01) 0.027 (0.005) 0.024 (0.006) 
AP COP 
Displacement (m) 0.026 (0.01) 0.006 (0.009) 0.004 (0.009)  0.003 (0.006) 0.005 (0.008) 0.007 (0.006) 
Peak COP  
Velocity (m/s) 1.20 (0.23) 1.10 (0.25) 0.53 (0.08)  1.24 (0.16) 0.58 (0.06) 0.37 (0.07) 
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STEADY STATE 
GAIT 
FLOOR ELEVATED 
CTRL PDON PDOFF CTRL PDON PDOFF 
Stride Length (m) 0.94 (0.05) 0.76 (0.04) 0.63 (0.04)  0.93 (0.05) 0.58 (0.04) 0.48 (0.03) 
Stride Velocity (m/s) 0.92 (0.05) 0.71 (0.04) 0.51 (0.04)  0.89 (0.05) 0.45 (0.04) 0.35 (0.04) 
AP COM  
Velocity (m/s) 1.02 (0.03) 0.84 (0.03) 0.69 (0.04)  0.98 (0.03) 0.59 (0.03) 0.45 (0.04) 
%DLS  15.3 (2.4) 22.0 (2.3) 24.4 (2.1)  14.8 (2.4) 25.0 (2.2) 33.8 (2.1) 
Table 3b:  Summary of descriptive statistics for steady state gait for each condition of postural threat.   
      Data are presented as mean ± standard error for each test group. 
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3.2. Gait Initiation 
3.2.1 PDOFF / CTRL 
3.2.1.1 Initiation Phase (INIT). The MANOVA revealed significant main effects for Group 
(F(1,18) =  7.03, p<.05, λ=.29), and Height (F(1,18) =  5.08, p<.05, λ=.36), and a  significant 
Group by Height interaction (F(1,18) =  3.83, p<.05, λ=.42). Follow-up univariate tests 
revealed that event time was the only measure to reach significance for the Group and 
Height main effects, while event time (F(1,18) =  6.76, p<.05) and AP COP displacement 
(F(1,18) =  4.26, p=.05) reached significance for the Group by Height interaction. PDOFF 
took significantly longer than CTRL subjects to initiate gait (F(1,18) = 5.16, p<.05; 
CTRL=0.387s; PDOFF= 0.882s), and event times for this phase were significantly longer in 
the elevated condition versus the floor condition (F(1,18) =  29.84, p<.05; Elevated=0.711s; 
Floor =0.557s). Follow-up comparisons showed that this effect of Height was driven by the 
PDOFF group, who took significantly longer to initiate gait in the elevated versus the floor 
condition (p= 0.026), while CTRL subjects showed no difference for this measure between 
testing conditions (Figure 10a). Moreover, PDOFF used significantly less AP COP 
displacement in the elevated testing condition for the INIT phase (p=0.036), while CTRL 
subjects did not alter the range of AP displacement during this phase. For all subjects, the 
direction of displacement during INIT was posterior (Figure 10b).  
3.2.1.2 Transfer Phase (TRANS). A main effect for Group (F(1,18) =  19.81, p<.05, λ=.13) 
emerged from the multivariate analysis, however, no significant results were revealed for 
Height or the Group by Height interaction. A follow-up univariate test showed that RST 
COP displacement (F(1,18) =  5.14, p<.05), ML COP displacement (F(1,18) =  5.40, p<.05), 
event time (F(1,18) =  8.53, p<.05), and peak COP velocity (F(1,18) =  10.54, p<.05) were 
significantly different between groups for this phase of gait initiation. In particular, PDOFF 
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showed less resultant COP displacement (p=.036; CTRL=0.052m; PDOFF= 0.033m) and less 
ML COP displacement than CTRL subjects (p=.032; CTRL=0.045m; PDOFF=0.025m). Yet, 
despite this reduced range of displacement, PDOFF took significantly longer to complete the 
TRANS phase than CTRL subjects (p=.009; CTRL=0.26s; PDOFF=0.60s). Consequently, 
PDOFF reached a significantly slower peak COP velocity than CTRL subjects during this 
phase (p= .004; CTRL=1.23m/s; PDOFF= 0.45m/s).  
3.2.2 PDON / CTRL 
3.2.2.1 Initiation Phase (INIT). No significant effects emerged for this phase of gait initiation. 
3.2.2.2 Transfer Phase (TRANS). Significant main effects for Group (F(1,18) =  11.10, p<.05, 
λ=.20) and Height (F(1,18) =  3.94, p<.05, λ=.42), and a significant Group by Height 
interaction (F(1,18) =  4.13, p<.05, λ=.40) were detected. Univariate follow-up testing 
showed that event time was the only measure to reach significance for the Group and 
Height main effects, while the Group by Height interaction was supported by the measures 
of event time (F(1,18) =  6.38, p<.05) and peak COP velocity (F(1,18) =  4.26, p=.05). PDON 
subjects took longer to complete the TRANS phase of gait initiation than CTRL subjects 
(F(1,18) =  11.39, p<.05; CTRL=0.26s; PDON=0.58s ), and regardless of group, event times 
for the TRANS phase were significantly longer in the elevated condition versus the floor 
condition (F(1,18) =  17.35, p<.05; ELEVATED=0.48s; FLOOR=0.36s). This main effect 
for Height was driven by the performance of the PDON group, who took significantly longer 
to complete the TRANS phase in the elevated condition compared to the floor condition 
(p=0.004), while CTRL subjects showed no differences between the two testing conditions 
(p>.05; Figure 10c). Similarly, PDON subjects showed a significantly reduced peak COP 
velocity (p=0.043) in the elevated height condition, despite having velocity values that 
approximated CTRL values for the floor condition (Figure 10d).  
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3.2.3 PDON / PDOFF   
3.2.3.1 Initiation Phase (INIT). A significant Height effect (F(1,18) = 6.50, p<.05, λ=.30) 
emerged from the multivariate analysis, however, no significant Group effect (F(1,18) =  
1.92, p>.05, λ=.59) or Group by Height interaction were revealed (F(1,18) =  2.27, p>.05, 
λ=.55). The univariate test showed that the main effect for Height was supported by the 
measures of event time (F(1,18) =  7.13, p<.05) and AP COP displacement (F(1,18) =  
12.54, p<.05). More specifically, both PDON and PDOFF took less time to initiate gait in the 
floor condition (PDON=0.60s, PDOFF=0.71s) than in the elevated condition (PDON=0.76s, 
PDOFF=1.04s). In addition, both PDON and PDOFF showed an increased amount of posterior 
displacement in the floor condition (PDON=0.017m, PDOFF=0.013m) than in the elevated 
condition (PDON=.007m, PDOFF=.002m). 
3.2..3.2 Transfer Phase (TRANS). A significant Height effect (F(1,18) = 3.57, p<.05, λ=.44) 
was detected from the multivariate analysis, however, no significant Group effect (F(1,18) =  
1.50, p>.05, λ=.65) or Group by Height interaction was revealed (F(1,18) =  1.67, p>.05, 
λ=.63). The univariate test showed that the main effect for Height was supported by the 
measures of event time (F(1,18) =  7.13, p<.05) and peak COP velocity (F(1,18) =  12.54, 
p<.05). Both PDON and PDOFF took less time to conduct the transfer phase in the floor 
condition (PDON=0.48s, PDOFF=0.53s) than in the elevated condition (PDON=0.67s, 
PDOFF=0.67s). In addition, both PDON and PDOFF showed a decrease in COP velocity in the 
elevated condition (PDON=0.58m/s, PDOFF=0.37m/s) than in the floor condition 
(PDON=1.10m/s, PDOFF=0.53m/s). 
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Figure 10. COP kinematics during gait initiation in floor and elevated (dark grey) testing conditions for control 
subjects (CTRL) and Parkinson’s disease patients on (PDON) and off (PDOFF) medication. Results illustrated 
represent measures that reached significance for a group by height interaction. Data provided represent mean ± 
standard error values. A) Initiation phase: event time, B) Initiation phase: COP displacement (posterior), C) Transfer 
phase: event time, D) Transfer phase: peak COP velocity. 
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3.3. Steady State Gait 
3.3.1 PDOFF / CTRL. The multivariate analysis revealed main effects for Group (F(1,18) =  
20.30, p<.05, λ=.16) and Height (F(1,18) =  4.22, p<.05, λ=.47 ), as well as a significant 
Group by Height interaction (F(1,18) =  3.48, p<.05, λ=.52). Follow-up comparison showed 
that PDOFF exhibit a shorter stride length (F(1,18)= 59.67, p<.05; CTRL=0.94m; 
PDOFF=0.56m ) and reduced stride velocity (F(1,18)= 52.15, p<.05; CTRL=0.91m/s; 
PDOFF=0.43m/s) compared to CTRL subjects. PDOFF subjects also had a slower AP COM 
velocity (F(1,18) =  80.76, p<.05; CTRL= 1.01m/s; PDOFF=0.58m/s ), and concurrently 
spent more time in double limb support (%DLS) (F(1,18) =  36.314, p<.05; CTRL=15.08%; 
PDOFF=29.12%) than CTRL subjects. Interestingly, stride length (F(1,18)= 4.31, p<.05; 
elevated=0.71m; floor=0.79m) and AP COM velocity (F(1,18)= 9.52, p<.05; 
elevated=0.72m/s; floor=0.86m/s) were reduced in the elevated condition compared to the 
floor condition. Univariate follow-up tests revealed that these measures were supported by 
Group by Height interactions (AP COM velocity: (F(1,18) =  4.90, p<.05), %DLS: (F(1,18) 
=  4.57, p<.05) (Figure 11a and 11b), and that significant Height effects for these measures 
emerged among the PDOFF group only. Specifically, PDOFF walked significantly slower in the 
elevated versus the floor condition (p=0.005), while CTRL subjects did not alter walking 
velocity between testing conditions. Similarly, PDOFF subjects spent a longer period of time 
in double limb support in the elevated condition compared to the floor condition (p=0.05), 
while CTRL subjects showed no significant differences (p>0.05). 
3.3.2 PDON / CTRL. Main effects for Group (F(1,18) =  8.10, p<.05, λ=.32 ) and Height 
(F(1,18) =  4.41, p<.05, λ=.46 ), and a significant Group by Height interaction (F(1,18) =  
3.00, p=.05, λ=.56 ) emerged from the MANOVA. PDON walked slower (F(1,18) =  25.75, 
p<.05; CTRL=1.01m/s; PDON=0.72m/s) and with a shortened stride length (F(1,18) =  
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27.03, p<.05; CTRL=0.94m; PDON=0.67m) than CTRL subjects. This resulted in a slower 
stride velocity (F(1,18) =  20.36, p<.05; CTRL=0.91m/s; PDON=0.59m/s) and a longer 
double limb support time (% DLS) (F(1,18) =16.23, p<.05; CTRL=15.08; PDON=24.01) 
compared to CTRL subjects.  In the elevated condition, participants walked slower (F(1,18) 
=  9.75, p<.05; elevated=0.79m/s ; floor=93m/s), with a shortened stride length (F(1,18) =  
5.08, p<.05; elevated=0.76m; floor=0.86m), and slower stride velocity (F(1,18) =  6.96, 
p<.05; elevated=0.67m/s; floor=0.82m/s) compared to the floor testing condition. There 
were no changes in % DLS time between testing conditions. Nevertheless, the Group by 
Height interaction showed that the manipulation of environmental context affected gait 
among PDON subjects differently than CTRL subjects. Specific differences emerged in AP 
COM velocity (F(1,18) =  5.25, p<.05), stride length (F(1,18) =  4.37, p=.05), and stride 
velocity (F(1,18) =  4.26, p=.05) (Figure 11a, 11c, and 11d). More specifically, PDON showed 
significantly slower walking speed (p=0.006), shorter stride length (p=0.006), and slower 
stride velocity (p=0.002) in the elevated condition versus the floor condition. CTRL subjects 
did not show any differences between testing conditions. 
3.3.3 PDON / PDOFF. A significant main effect for Height (F(1,18) =  12.11, p<.05, λ=.24) 
was revealed through the multivariate analysis. However, a Group by Height (F(1,18) = .92, 
p>.05, λ=.80) interaction failed to emerge even though a main effect for Group (F(1,18) = 
2.48, p=.08, λ=.60) did approach significance. Stride length (p=.000), stride velocity 
(p=.000), AP COM velocity (p=.000), and %DLS (p=.034) were all found to be significantly 
different between height conditions. 
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Figure 11. Steady-state gait kinematics in floor and elevated (dark grey) testing conditions for control subjects (CTRL) 
and Parkinson’s disease patients on (PDON) and off (PDOFF) medication. Results illustrated represent measures that 
reached significance for a group by height interaction. Data provided represent mean ± standard error values. A) AP 
COM Velocity, B) %DLS, C) Stride Length, D) Stride Velocity. 
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4.0 Discussion 
The purpose of this study was to determine how environmental context influences 
locomotor control among patients with PD. Healthy adult control participants and PD 
patients in both a non-medicated and medicated state were asked to initiate gait and continue 
with steady state gait in two environmental contexts that differed in the potential 
consequences of instability should a fall occur. Our results showed that in the absence of 
levodopa therapy, PD patients exhibited exacerbated deficits in gait initiation and steady 
state gait in the elevated compared to the floor condition. In addition, our findings 
demonstrated that medicated PD patients showed comparable results with CTRL subjects in 
the floor condition, however, in the elevated condition medicated PD patients showed 
deficits similar to their non-medicated state. These findings suggest that: 1) gait initiation and 
steady state gait deficits inherent to PD are aggravated in an environmental context that 
presents a threat to postural control and 2) medication efficacy for overcoming parkinsonian 
deficits may be context dependent. These findings confirm the dynamic nature of 
parkinsonian motor deficits (Morris, 2000) and provide empirical support for specific 
situations that can create movement deficits for PD patients.  
Previous research has shown that parkinsonian deficits in gait initiation and steady 
state gait are characterized by a decreased velocity and a reduction in movement amplitude 
typical of bradykinesia (Crenna & Frigo, 1991; Halliday et al., 1998; Morris et al., 2005; 
Nallegowda et al., 2004; O'Sullivan, Said, Dillon, Hoffman, & Hughes, 1998). For gait 
initiation these effects emerge as decreased velocity during the INIT and TRANS phase. For 
steady state gait, a slower walking velocity, characterized by an increase in DLS time, 
decrease in stride length, and stride velocity exemplify the difficulties PD patients encounter 
when walking (Morris et al., 2005). Our findings substantiate this well documented 
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phenomenon by demonstrating that regardless of context PDOFF show significant reductions 
in movement amplitude and velocity for gait initiation and steady state gait compared to 
CTRL subjects. Our findings also support a beneficial effect of parkinsonian medications for 
alleviating the deficits observed in gait initiation and steady state gait (Morris et al., 2005; 
Nallegowda et al., 2004; O'Sullivan et al., 1998), with PDON showing improvement beyond 
the non-medicated state. These changes however, emerged only in the non-threatening 
context. 
A key finding from our study was that parkinsonian deficits typical of gait initiation 
and steady state gait were aggravated in the threatening context. This effect was revealed by 
temporal and spatial COP kinematics during gait initiation and gait cycle kinematics during 
steady state gait among non-medicated patients. Specifically, during the INIT phase of gait 
initiation PDOFF  required a longer duration of time, yet moved through a shorter range of 
displacement when comparing the elevated and floor conditions. Deficits in steady state gait 
were manifest among PDOFF as a decreased walking speed with a greater proportion of the 
gait cycle spent in the DLS phase. Concurrently, there was also a trend for stride length to 
decrease in the threatening environmental context among PDOFF. These findings confirm 
that parkinsonian bradykinesia is exacerbated by situational context. 
The most compelling finding we present is that the PD response to levodopa therapy 
for alleviating motor deficits associated with gait initiation and steady state gait was context 
dependent. Specifically, improvements in timing and amplitude parameters of gait initiation 
and gait typically associated with levodopa medication (Burleigh-Jacobs et al., 1997; Morris et 
al., 2005) emerged only in the non-threatening context. In particular, event time and peak 
COP velocity within the TRANS phase of gait initiation, as well as gait velocity, stride 
length, and stride velocity for steady state gait showed significant improvements following 
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medication in the non-elevated condition, but there were no significant changes beyond 
non-medicated state in the elevated testing condition. This finding presents the possibility 
that the efficacy of medication therapy for overcoming movement deficits is compromised 
in a threatening environmental context. One implication of context-dependent drug efficacy 
is that PD patients when encountering a postural challenging situation may experience an 
increase in movement difficulty, despite the possibility of not experiencing any difficulties in 
a non-challenging situation. An alternate explanation to this proposition is that medication 
efficacy is not compromised in the elevated testing condition, and PD patients responded to 
the threatening context by adopting extremely conservative movement patterns. Although 
this may be the case, the effectiveness of these movement pattern alterations for reducing 
fall risk cannot be determined from the present study. However, we suggest that the 
similarity of these adaptations to parkinsonian bradykinesia and akinesia will limit the 
capacity for timely reactive movements such as would be necessary when required to 
preserve stability under time-restricted conditions, for example if an obstacle suddenly 
appeared underfoot (McKenzie & Brown, 2004). To this end we expect that the movement 
pattern alterations that emerged among PD patients in the elevated testing condition, which 
are not alleviated by levodopa, will not be beneficial to reducing fall risk. Our current work is 
exploring this possibility. 
Contrary to parkinsonian patients, CTRL subjects did not alter movement patterns 
when the environmental context presented heightened consequences of instability. These 
findings contradicted previous work from our laboratory that demonstrated older adults do 
modify gait kinematics when postural threat is heightened. We suggest that the wider 
walkway used in this study was insufficient to impose the level of threat necessary to 
necessitate movement modifications among CTRL subjects.  
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4.1 Context dependent changes in PD gait initiation and gait: Potential underlying mechanisms 
 Morris et al (2000) argue that PD patients rely on conscious processes to regulate 
movements that, for the non-parkinsonian population, require little conscious input. One 
implication to arise from this theory is that motor performance may be compromised in 
situations that impose added cognitive demands. Indeed, carrying a tray of glasses while 
walking (Bond & Morris, 2000) or talking while walking are two situations that have been 
shown to change parkinsonian walking patterns (Bloem, Grimbergen, Cramer, & 
Valkenburg, 2000). In previous work from our laboratory (Brown, Gage et al., 2002) we 
demonstrated that walking in an environmental context that threatens postural control, such 
as the testing conditions imposed in this study, is more attentionally demanding than walking 
in a non-threatening context. One explanation for the added demand is that participants 
direct attention to the source of the threatening stumuli (Williams, Hadjistavropoulos, & 
Asmundson, 2004); a draw for attentional resources that is unnecessary if threat is absent. In 
the protocol of the study, this threat was presented by the environment in which the 
movement is being performed. Therefore, it remains possible that the changes in locomotor 
control that emerged among PD patients (on/off) in the threatening context reflect a 
compromised capacity to consciously regulate motor output in this testing condition. To this 
end, we suggest that the capacity to consciously regulate movement may be limited by the 
added ‘draw’ for attentional resources that is presented by the threatening environmental 
context.  
Curiously, parkinsonian medication was less effective for overcoming movement 
deficits in the threatening environment than it was in the non-threatening environment. This 
finding may represent a detrimental effect of anxiety on medication efficacy. Recent research 
has shown that anxiety is significantly more prevalent in PD patients compared to age 
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matched adults without the disease (Walsh & Bennett, 2001). In addition, it has been noted 
that an increase in anxiety may be associated with decreased mobility in PD patients (Walsh 
& Bennett, 2001), suggesting that parkinsonian medication may not be as effective when 
anxiety levels are increased. Interestingly, abnormalities in the dopaminergic system have 
been thought to play a major role in the elevated levels of anxiety that PD patients 
experience.  Both the ventral tegmental area (dopamine projection) and the locus ceruleus 
show substantial change in neurochemical activity in PD patients. Dopamine inhibits the 
firing rate of the locus ceruleus and the loss of dopaminergic inhibition that results from PD 
degeneration is proposed to cause the increase in both trait and state anxiety (Walsh & 
Bennett, 2001). The implications of this finding suggest that in the present study the 
exacerbated movement deficits may be the result of increased anxiety concomitant with 
insufficient dopaminergic inhibition. PD patients have decreased levels of endogenous 
dopamine and the use of synthetic dopamine replacement can restore dopaminergic 
functions. This is evident in the floor condition with medicated PD patients showing 
significant reductions of movement deficits compared to non-medicated patients. However, 
conventional dopamine dosages do not provide adequate inhibition to control anxiety 
responses in challenging environments and anxiety-evoked movement deficits result. The 
end result is that medicated PD patients perform similar to non-medicated patients in the 
high threat condition which may be increasingly dangerous if they are expecting to have full 
medication benefits. Regardless, these results show that the benefit of levodopa medication 
is compromised in a postural threatening environment.  
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5.0 Conclusion  
 Gait initiation and steady state gait are dynamic locomotor movements that require 
challenging control of COP and COM. These tasks become more difficult for PD patients, 
and as our results show become increasingly difficult in a postural threatening environmental 
context. Our findings indicate that PD patients have significant deficiencies in gait initiation 
and steady state gait compared to CTRL subjects and that these deficits are exacerbated by 
postural threat. PD patients in the absence of medication show a bradykinesia that is beyond 
typical parkinsonian slowness in the postural threatening environment. In addition, PD 
patients in their medicated state show that the effectiveness of their medication may be 
context dependent. These results have significant implication for PD patients especially 
under situations that require additional attention (ie. crossing a street, walking in a crowd) or 
environments that may create anxiety from a fear of falling (ie. slippery sidewalks, steep 
stairs). 
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General Discussion 
 This thesis compared how patients with PD and age matched older adults without 
PD alter the regulation of locomotion in an environmental context that presents a threat to 
postural control. In addition, this thesis examined the context dependent efficacy of 
parkinsonian medication for alleviating locomotor deficits. These questions were addressed 
for the tasks of gait initiation and steady state gait. The postural threat paradigm consisted of 
two different testing conditions, a low threat non-elevated (FLOOR) condition and a high 
threat elevated (ELEVATED) condition as per previous work from our laboratory. Both 
healthy older adults (CTRL) and PD patients initiated gait and continued walking along a 
walkway in these two conditions. PD patients were tested in a non-medicated and medicated 
state within the same day.  
1. Effects of Postural Threat on Gait Initiation and Steady State Gait 
 Results from this thesis confirm and support the findings from previous studies 
regarding PD deficits for the tasks of gait initiation and steady state gait. Specifically, PD 
patients relative to CTRL subjects exhibited significant deficits when initiating gait and 
walking. Moreover, PD deficits were exacerbated in a non-medicated state. Previous studies 
have documented that non-medicated PD patients have reduced lateral and posterior COP 
displacement and slower velocity during gait initiation (Burleigh-Jacobs et al., 1997) and 
smaller stride length, increased DLS time, and slower walking velocity (Morris et al., 2005) 
during steady state gait compared to medicated PD patients. Our results substantiate these 
findings and provide additional evidence for context-dependent medication efficacy for PD 
patients in these types of movement tasks.  
 The unique finding presented in this thesis was that PD deficits are exacerbated in a 
postural threatening environment. More specifically, our results suggest that in a threatening 
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environmental context non-medicated PD patients show deficits that are beyond their 
typical levels of parkinsonian movement difficulty. In particular, when the environmental 
context presented a threat to postural control, PDOFF patients showed an increase in timing, 
reduced magnitude of COP displacement, and slower COP velocity for both the INIT and 
TRANS phases of gait initiation. For steady state gait, PDOFF movement was characterized 
by a reduced walking velocity, increased time in DLS, decreased stride length, and a reduced 
stride velocity. 
 The most compelling result to emerge from this thesis was that the effectiveness of 
parkinsonian medication for overcoming the movement difficulties associated with gait 
initiation and gait appears to be context dependent.  Specifically, the effectiveness of PD 
medication for overcoming the deficits that emerged in the non-medicated state was limited 
to the non-threatening (floor) testing condition.  This finding was demonstrated by an 
increase in event time, reduced COP displacement, and decreased velocity compared to the 
floor condition in both phases of gait initiation. For steady state gait, compromised 
medication efficacy was demonstrated by a slower walking velocity, increased time spent in 
DLS, reduced stride length, and a slower stride velocity of steady state gait. This finding 
provides a unique contribution to the literature, demonstrating a confirmed effect for 
environmental context on medication efficacy.  
 Unlike PD patients, our CTRL subjects did not show any variations to their 
movement patterns in the elevated testing condition. This is in contrast to previous research 
from our laboratory in which it was concluded that older adults exhibit modifications to gait 
kinematics in an environmental context of increased postural threat. (Brown, Gage et al., 
2002; Gage et al., 2003; McKenzie & Brown, 2004). A wider walkway and possible disparity 
in subject demographics (ie. number of previous falls, fear of falling, physical activity levels) 
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between healthy older adult groups provide reasons for the differences between the current 
results and previous findings using this paradigm.  
2. Potential Mechanisms: Implications of Results 
 The first proposed explanation for the observed movement deficits is based on the 
notion that PD patients are allocating more of their attention to the postural threatening 
environment. As such, PD patients are leaving less cognitive capacity available to 
concentrate on executing movement. This theory is based on the premise presented by 
Morris et al. (2004) where it is argued that PD patients rely more heavily on conscious 
attentional motor control processes compared to CTRL subjects in order to bypass defective 
basal ganglia. The simultaneous need to concentrate on environment and task is proposed to 
account for the difficulties that PD patients have in challenging environments (Rochester et 
al., 2004). Since the pharmacological schedule for drug therapy promotes constant 
medication dosing, PD patients rarely experience the full ‘OFF’ state tested in this study 
(Playfer, 2001). Consequently, these results lend themselves to the common reported effect 
of “wearing-off”, which happens when parkinsonian medication levels are not at peak dose 
and are at the end of a medication cycle (Jankovic, 2002). In this instance, it is important for 
PD patients to realize that when faced with a challenging situation they will be vulnerable to 
experiencing movement difficulties. Moreover, although PD medication can alleviate 
movement deficits, these benefits seem limited to non-challenging situations. The results 
presented in this thesis imply that in a non-challenging situation medication efficacy is 
beneficial to overcoming movement deficits. However, when faced with a situation that may 
impose a threat to postural control (ie. slippery sidewalks, steep stairs), the benefits of 
parkinsonian medication may be compromised. This finding carries the implication that 
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encountering a postural challenging situation may increase the risk for movement difficulties 
beyond the inherent risk associated with this disease. 
 The second explanation that cannot be overlooked is the notion that perhaps PD 
patients in the increased postural threat environment are adapting their movement to comply 
with a more conservative or safe behavior. Previous research in this area has confirmed that 
the gait pattern alterations adopted by non-neurological older adults in the threatening 
context serve well to reduce the risk of falling (Brown, Polych, & Doan, in press). Although 
this may be the case for the results presented in this thesis, it is hypothesized that a 
conservative movement strategy for PD patients may be detrimental. More specifically, if 
movement amplitude and velocity are substantially minimized, the necessary force 
production and displacement of COP and COM could lead to an inability to create 
successful and meaningful movements, with the most severe circumstance resulting in 
freezing of gait and the subsequent loss of balance. 
 A unique finding to emerge from this thesis is that medication efficacy is reduced in 
a postural threatening environment. This finding suggests that medication efficacy is context 
dependent. One possible explanation for the unresponsiveness of parkinsonian medication 
in the postural threatening environment may be the detrimental effect of anxiety on 
medication efficacy. It has been reported that 5% - 40% of the PD population experience 
some form of anxiety (Starkstein, Robinson, & Leiguardia, 1993). Interestingly, PD patients 
have shown to have a decrease in mobility when anxiety levels increase, leading to the notion 
that perhaps the reduction in mobility is associated with an attenuation in medication 
efficacy (Walsh & Bennett, 2001). The results presented in this thesis seem to support such a 
notion, as medicated PD patients showed an increase in movement deficits when the 
environmental context became more challenging. It is unknown if the PD patients in the 
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present study had an increase in anxiety levels in the elevated testing condition. However, 
previous studies from our laboratory that have utilized the same postural threat paradigm 
and have been able to show that anxiety levels increase in response to an increase in postural 
threat. Taken together these results suggest that medication efficacy may be compromised in 
the elevated threat condition because of an increase in anxiety. 
3. Implications for Therapy 
 The findings presented in this thesis suggest an integral role for assisting in the 
development of therapeutic strategies for managing situations of daily living. Typical 
assessments of PD impairment, such as the single-task measures of gait, may offer little 
insight into actual difficulties patients could have in home environments, busy streets, and 
changes in walking surface (Rochester et al., 2004). However, based on the results presented 
in this thesis, it is possible that the degree of movement impairment can be better 
understood when the movement is required to meet context demands. Consequently, 
therapeutic interventions can be prescribed accordingly. Visual, auditory, and cutaneous cues 
are types of therapeutic interventions that have been shown to improve the spatial and 
temporal parameters of locomotion for PD patients. In non-challenging situations visual and 
auditory cues have been shown to improve the gait parameters of stride length and stride 
velocity (Darmon, Azulay, Pouget, & Blin, 1999), while cutaneous cues have been successful 
in improving the timing associated with gait initiation (Burleigh-Jacobs et al., 1997; Dibble et 
al., 2004). However, implications of this thesis suggest that therapists using sensory cues as a 
therapeutic intervention should consider the medication level of PD participants and the 
environmental context in which these cues are used. In situations where the environment 
requires a challenge in postural control or redirection of attention, the degree of movement 
difficulty may outweigh the benefits of such a strategy. 
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4. Future Research   
 The results presented in this thesis offer the foundation for further research in this 
field. Future research in the areas of obstacle negotiation, fear of falling, and dual-task 
paradigms that involve a postural threat environment could yield new knowledge regarding 
the movement capabilities of patients with PD. Obstacle negotiation research could offer 
unique insight into how PD patients both medicated and non-medicated respond to 
situations that challenge both their attention to a task and how successful they are at 
completing the task. The implications for such research would have significant real-world 
application. Research in this area could give greater insight into the role of extrinsic factors 
and the possibility for falls in the PD population. As well, future research is needed to 
explore how PD patients who are identified as having a fear of falling modulate their 
movement in a postural challenging context, and at the same time the benefits or detriments 
of using a more conservative approach to movement could be assessed. These results would 
be important to the further understanding of the psychological constraints of fear of falling 
on movement in challenging environments.  
5. Limitations of Study 
 Some limitations of this thesis must be acknowledged. First, the PD patients 
included in this study were tested both in a non-medicated and medicated state. The UPDRS 
scale was used to ensure a difference between medication states, however subjects were only 
given one hour to be considered medicated. It is possible that PD patients did not reach 
peak dose in their medication cycle until later. Thus, the reported ‘on’ state of our subjects 
may not be a true measure of the full benefit of parkinsonian medication or indicative of 
capable movement behavior when medicated for a longer period of time. 
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 The second limitation of this thesis is the inability to use collected galvanic skin 
conductance (GSC) data. GSC measures the perspiration of the skin, and more specifically 
perspiration of the fingers. GSC is a validated and reliable measure of anxiety (Ashcroft, 
1991; Naveteur & Roy, 1990). GSC was collected for each subject and for all trials, however 
due to unforeseen problems with the hardware used to collect GSC, the corresponding data 
was unusable. This is unfortunate because it would have added to the findings of this study, 
as the observed results could have also been attributed to increased levels of anxiety in our 
PD patients in the elevated condition. Previous studies that have used this postural threat 
paradigm have collected GSC and results have shown that as the environmental context 
becomes more challenging, subjects become more anxious. In addition, previous work has 
shown that anxiety modifies gait parameters (Brown, Gage et al., 2002; Gage et al., 2003; 
McKenzie & Brown, 2004). However, in the present study it is uncertain if PD patients were 
more anxious than CTRL subjects or all subjects were equally as anxious. Future research is 
needed to substantiate this notion. 
6. Conclusion 
The purpose of this thesis was to investigate the effect of environmental context on 
locomotor control among patients with PD. The results presented in this thesis suggest that 
environmental context exacerbates the deficits associated with PD and that medication 
efficacy may be context dependent. 
Results from this thesis support previous findings in the area of gait initiation and 
gait, but also provide experimental support for the effects of environmental context on 
movement patterns in PD patients. A compelling finding of this thesis is that PD movement 
deficits in the absence of levodopa therapy were exacerbated in the threatening 
environmental context. These findings confirm that parkinsonian bradykinesia is exacerbated 
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by situational context. Yet, the most compelling finding presented in this thesis is that 
medicated PD patients have a reduction in medication efficacy in an environmental context 
that presents instability. These results suggest that parkinsonian medication may be context 
dependent, and offer unique insight for the design and implementation of therapeutic 
strategies for the care and management of Parkinson’s disease. 
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